Saturday, 11 January, 2025
By Saroj Dhungel, Kathmandu, Mar. 19: The Department of Drug Administration (DDA) has given approval to 'Covaxin', a vaccine against novel coronavirus, for emergency use in Nepal.
Covaxin is being produced by an Indian company called Bharat Biotech International Limited.
Bharat Bhattarai, Director General at the DDA informed The Rising Nepal that approval had been given to use Covaxin in emergencies.
With this, the number of companies receiving Nepal's approval for use has reached three. Prior to this, Covishield and Sinopharm had received the government's nod for emergency use.
Similarly, Bhattarai said that two more companies producing COVID-19 vaccines had filed applications at the department for approval. "Russia's Sputnik V and China's Sinovac have applied to receive approval for use," he said.
Director-General Bhattarai added that the technical team of the department was investigating the vaccines.
The DDA gave approval to Covaxin on Friday on the recommendation of the Drug Advisory Committee.
Do not make expressions casting dout on election: EC
14 Apr, 2022
CM Bhatta says may New Year 2079 BS inspire positive thinking
14 Apr, 2022
Three new cases, 44 recoveries in 24 hours
14 Apr, 2022
689 climbers of 84 teams so far acquire permits for climbing various peaks this spring season
14 Apr, 2022
How the rising cost of living crisis is impacting Nepal
14 Apr, 2022
US military confirms an interstellar meteor collided with Earth
14 Apr, 2022
Valneva Covid vaccine approved for use in UK
14 Apr, 2022
Chair Prachanda highlights need of unity among Maoist, Communist forces
14 Apr, 2022
Ranbir Kapoor and Alia Bhatt: Bollywood toasts star couple on wedding
14 Apr, 2022
President Bhandari confers decorations (Photo Feature)
14 Apr, 2022
